Clinical Trials Directory

Trials / Sponsors / Connect Biopharm LLC

Connect Biopharm LLC

Industry · 12 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingRademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
COPD Acute Exacerbation
Phase 22025-08-12
RecruitingRademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)
Asthma Acute
Phase 22025-08-08
CompletedA Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects
Healthy Adult Subjects
Phase 12023-07-18
UnknownA Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
Atopic Dermatitis
Phase 22023-07-15
WithdrawnCBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
Phase 32022-12-01
CompletedA Study On Human Mass Balance And Biotransformation
Healthy Adult Subjects
Phase 12021-09-04
CompletedA Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
Moderate-to-severe Atopic Dermatitis
Phase 22021-08-31
TerminatedA Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Phase 22021-06-16
CompletedEfficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
Moderate to Severe Persistent Asthma
Phase 22021-05-11
CompletedA Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatit
Moderate-to-severe Atopic Dermatitis
Phase 22020-07-17
CompletedA Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (U
Moderate to Severe Ulcerative Colitis
Phase 22019-02-27
CompletedPhase 1 Study Accessing the Safety and Tolerability of CBP-307
Autoimmune Diseases
Phase 12014-11-01